IHS Chemical Week

EnviroTech :: R&D

Novartis to Invest $1 Billion on R&D Center in China; Opens $250-Million API Site at Changshu

4:49 AM MST | November 3, 2009 | Deepti Ramesh

Novartis says it will invest $1 billion over the next five years, to increase pharmaceutical research and development (R&D) activities in China. The investment will involve a significant expansion of the Novartis Institute of BioMedical Research (CNIBR) at Shanghai, the company says. Novartis says it has also invested $250 million in a new technical center at Changshu, China, which opened this week, and the center is focused on technical research, development and manufacturing of active pharmaceutical ingredients (APIs). The facility is expected to be a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa